Clinical Trial Update: ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating ZoNantax (zoledronic acid) as neoadjuvant therapy combined with anthracycline and taxane in locally advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ZoNantax (zoledronic acid)

Snippet

Sponsor: Susanne Crocamo | Conditions: Breast Cancer, Breast Disease | Phase 2 | Status: COMPLETED